You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen receptor

Showing 51 - 75 of 8,225
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 11C or 18F-Choline PET/CT, Whole body MRI)

Completed
  • Prostate Cancer Metastatic
  • Leiden, Netherlands
    Leiden University Medical Center
Apr 6, 2022

AR, IGF-IR, IR and Peripheral Artery Disease

Recruiting
  • Androgen Receptor Abnormal
  • +2 more
  • arterial reconstructive open surgery
  • Catanzaro, Italy
    University Magna Graecia of Catanzaro
Jan 12, 2021

Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining

Completed
Has Results
  • Breast Cancer
  • San Francisco, California
  • +7 more
Jul 8, 2022

Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in United States (GnRH

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • GnRH agonist/antagonist
  • +3 more
  • Los Angeles, California
  • +3 more
Apr 30, 2021

Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • San Francisco, California
    University of California San Francisco
Sep 20, 2022

Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)

Withdrawn
  • Prostate Cancer
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    Johns Hopkins University
Dec 14, 2021

COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene

Enrolling by invitation
  • Covid19
  • Androgen Receptor Gene Overexpression
  • COVID-19 Androgen Sensitivity Test (CoVAST)
  • Irvine, California
  • +1 more
Dec 9, 2020

Triple Negative Breast Cancer Trial in United States (ribociclib, Bicalutamide)

Recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
  • +5 more
Oct 31, 2022

Prostate Cancer Trial in Ann Arbor, Detroit (ARRx, Enzalutamide)

Suspended
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +1 more
Dec 17, 2021

Metastatic Castrate-resistant Prostate Cancer, Adenocarcinoma, Prostate Trial in United States (TRC253)

Completed
Has Results
  • Metastatic Castrate-resistant Prostate Cancer
  • Adenocarcinoma, Prostate
  • Birmingham, Alabama
  • +4 more
Mar 29, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory

Active, not recruiting
Has Results
  • Castration Levels of Testosterone
  • +9 more
  • Recombinant EphB4-HSA Fusion Protein
  • Los Angeles, California
  • +2 more
Apr 4, 2022

Prostate Cancer Trial in New Brunswick, Seattle, Madison (pTVG-AR, gm-csf)

Completed
  • Prostate Cancer
  • pTVG-AR
  • gm-csf
  • New Brunswick, New Jersey
  • +2 more
Feb 2, 2021

Ann Arbor Stage I Mantle Cell Lymphoma, Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma Trial

Terminated
Has Results
  • Ann Arbor Stage I Mantle Cell Lymphoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 16, 2021

Pancreatic Cancer Trial in Tampa (Enzalutamide, Gemcitabine, Nab-paclitaxel)

Completed
  • Pancreatic Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 16, 2021

Prostate Cancer Metastatic Trial in France (Darolutamide 300 mg, Placebo, Androgen deprivation therapy)

Recruiting
  • Prostate Cancer Metastatic
  • Darolutamide 300 mg
  • +2 more
  • Avignon, France
  • +44 more
Sep 28, 2022

Benign Prostatic Hyperplasia Trial in United States (Group-1 (15mg, OPK-88004), Group-2 (25 mg,OPK-88004), Placebo)

Terminated
Has Results
  • Benign Prostatic Hyperplasia
  • Group-1 (15mg, OPK-88004)
  • +2 more
  • Anniston, Alabama
  • +14 more
Aug 23, 2021

Metastatic Breast Adenocarcinoma, Breast Cancer Trial in Switzerland (CR1447)

Active, not recruiting
  • Metastatic Breast Adenocarcinoma
  • Breast Cancer
  • Aarau, Switzerland
  • +12 more
Feb 3, 2022

Prostate Cancer Trial in Vienna (PSMA PET Scan, FDHT PET Scan)

Recruiting
  • Prostate Cancer
  • PSMA PET Scan
  • FDHT PET Scan
  • Vienna, Austria
    Medical University of Vienna
Oct 25, 2021

Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Acapatamab, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Birmingham, Alabama
  • +13 more
Jun 20, 2022

Triple Negative Breast Cancer Trial in United States (GTx-024)

Terminated
Has Results
  • Triple Negative Breast Cancer
  • Fort Lauderdale, Florida
  • +6 more
Oct 29, 2020

Metastatic Triple Negative Breast Cancer Trial in Guangzhou (TPC, Bicalutamide 150 mg)

Terminated
  • Metastatic Triple Negative Breast Cancer
  • TPC
  • Bicalutamide 150 mg
  • Guangzhou, Guangdong, China
  • +1 more
Jan 26, 2021

ER+ and AR+ Breast Cancer Trial in United States (GTx-024)

Completed
Has Results
  • ER+ and AR+ Breast Cancer
  • Fort Lauderdale, Florida
  • +3 more
Dec 8, 2020

Prostatic Tumors Trial in Canada, United States (Niraparib, Apalutamide, Abiraterone Acetate)

Completed
  • Prostatic Neoplasms
  • West Hollywood, California
  • +5 more
Jul 16, 2020

Metastatic Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma, Prostate Carcinoma Metastatic to the Bone Trial in Duarte,

Completed
  • Metastatic Prostate Carcinoma
  • +2 more
  • Robotic Assisted Radical Prostatectomy
  • +4 more
  • Duarte, California
  • +2 more
Apr 7, 2021

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Birmingham, Detroit, Columbus

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +2 more
  • Birmingham, Alabama
  • +3 more
Mar 2, 2021